Researchers have identified a biological mechanism linking a newborn's genetic switches to the bacteria that colonize the infant gut, and from there to the child's risk of developing autism spectrum disorder and attention-deficit hyperactivity disorder by age three.
The discovery, published in Cell Press Blue, involved tracking epigenetic patterns present in umbilical cord blood from 571 babies, comparing those findings with gut microbiome samples taken from nearly 970 infants at 2, 6, and 12 months of age, and then assessing developmental outcomes at 36 months. The scale and depth of the analysis revealed what researchers call a conversation between the body's genetic programming and its microbial ecosystem.
Two specific bacterial species emerged as potentially protective. Children carrying epigenetic markers associated with autism showed fewer signs of the condition when they acquired Lachnospira pectinoschiza early in life. Those with ADHD-linked epigenetic patterns fared better behaviorally if they hosted Parabacteroides distasonis in their first year.
"Certain bacteria seem to offer protection, which is exciting because it suggests there could be ways to support a child's development through diet or probiotics in the future," said Francis Ka Leung Chan, senior author and gastroenterologist at The Chinese University of Hong Kong.
The research traced how the infant microbiome develops, revealing distinct influences at play. Delivery method, antibiotic use, having older siblings, and breastfeeding all shaped which microbes colonized each child's gut. Babies born via Caesarean section showed different DNA methylation patterns in immune-related genes compared to those delivered vaginally, a difference that echoed through the microbiome's evolution.
Infants with higher levels of DNA methylation in immune genes developed less diverse gut communities by one year of age. This finding suggests the body's genetic regulatory mechanisms at birth help orchestrate which microorganisms take hold and flourish during infancy.
The window between birth and age three represents a critical period when both brain development and immune maturation proceed rapidly. Scientists have long known that epigenetics and gut bacteria each influence lifelong health, but the interaction between these systems during early childhood remained poorly understood until now.
Co-senior author Hein Min Tun of The Chinese University of Hong Kong emphasized that the results do not imply a child's developmental trajectory is fixed before birth. "These are complex conditions with many causes, and we've only uncovered a small piece of a very large puzzle," Tun said.
The research team will continue monitoring the participating children to track how early epigenetic patterns and microbiome composition influence health through later childhood. Laboratory studies will be necessary to confirm the observed relationships and understand the biological mechanisms by which specific bacteria may reduce neurodevelopmental risk.
Siew Chien Ng, first author and gastroenterologist at The Chinese University of Hong Kong, outlined the next frontier: "The ultimate goal is to develop safe, non-intrusive early interventions such as specific probiotics or live biotherapeutics, that could help nurture a healthy gut microbiome and potentially reduce the risk of neurodevelopmental challenges."
Author Jessica Williams: "This work opens a real door to prevention rather than just diagnosis and treatment, but the gap between what bacteria correlate with better outcomes and what actually causes those outcomes is still wide."
Comments